TickerFacts.

A business in context

ACAD research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-09-24 · 0001193125-26-401157 · Items 7.01,8.01,9.01

  2. 8-K · Current report

    Report date 2026-09-11 · 0001193125-26-389400 · Items 8.01,9.01

  3. 4 · Ownership change

    Report date 2026-08-05 · 0001899977-26-000008

  4. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-333243

  5. 8-K · Current report

    Report date 2026-08-04 · 0001193125-26-332858 · Items 2.02,9.01

  6. 4 · Ownership change

    Report date 2026-07-29 · 0001861477-26-000005

  7. 4 · Ownership change

    Report date 2026-06-26 · 0001816160-26-000009

  8. 4 · Ownership change

    Report date 2026-05-29 · 0001193125-26-253632

  9. 4 · Ownership change

    Report date 2026-05-29 · 0001865210-26-000002

  10. 4 · Ownership change

    Report date 2026-05-29 · 0001826361-26-000002

  11. 4 · Ownership change

    Report date 2026-05-29 · 0001604689-26-000009

  12. 4 · Ownership change

    Report date 2026-05-29 · 0001560782-26-000002

  13. 8-K · Current report

    Report date 2026-05-29 · 0001193125-26-248242 · Items 5.02,5.07,9.01

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-209731

  15. 8-K · Current report

    Report date 2026-05-06 · 0001193125-26-209253 · Items 2.02,9.01

  16. 8-K · Current report

    Report date 2026-04-27 · 0001193125-26-197957 · Items 5.02,7.01,9.01

  17. DEF 14A · Proxy statement

    Report date 2026-05-29 · 0001193125-26-174163

  18. 8-K · Current report

    Report date 2026-03-03 · 0001193125-26-092213 · Items 5.02

  19. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-072519

  20. 8-K · Current report

    Report date 2026-02-25 · 0001193125-26-071674 · Items 2.02,9.01

  21. 8-K · Current report

    Report date 2026-01-13 · 0001193125-26-011706 · Items 2.02,7.01,9.01

  22. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-267453

  23. 8-K · Current report

    Report date 2025-11-05 · 0001193125-25-266959 · Items 2.02,9.01

  24. 8-K · Current report

    Report date 2025-10-28 · 0001193125-25-262610 · Items 5.02

  25. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-104295

  26. 8-K · Current report

    Report date 2025-08-06 · 0000950170-25-104092 · Items 2.02,9.01

  27. 8-K · Current report

    Report date 2025-06-09 · 0001193125-25-138452 · Items 8.01

  28. 8-K · Current report

    Report date 2025-05-29 · 0001193125-25-130620 · Items 5.07

  29. 8-K · Current report

    Report date 2025-05-15 · 0001193125-25-123175 · Items 1.01,8.01

  30. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-066231

  31. 8-K · Current report

    Report date 2025-05-07 · 0000950170-25-065672 · Items 2.02,9.01

  32. DEF 14A · Proxy statement

    Report date 2025-05-29 · 0000950170-25-058827

  33. 8-K · Current report

    Report date 2025-04-15 · 0001193125-25-082809 · Items 5.03,9.01

  34. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-029253

  35. 8-K · Current report

    Report date 2025-02-26 · 0000950170-25-027759 · Items 2.02,9.01

  36. 8-K · Current report

    Report date 2024-12-11 · 0001193125-24-275595 · Items 2.01

  37. 8-K · Current report

    Report date 2024-11-18 · 0001193125-24-262556 · Items 5.02

  38. SC 13G/A · Ownership disclosure

    0000902664-24-006501

  39. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-122513

  40. 8-K · Current report

    Report date 2024-11-06 · 0000950170-24-122322 · Items 2.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 5 transaction rows5SGrant / award: 0 transaction rows0AExercise / conversion: 6 transaction rows6MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

11 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-08-06
2026-08-07
Schneyer Mark C.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock5000.029.0
2026-08-06
2026-08-07
Schneyer Mark C.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock9292.029.34
2026-08-06
2026-08-07
Schneyer Mark C.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock14292.017.84
2026-08-06
2026-08-07
Schneyer Mark C.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
14292.00.0
2026-08-05
2026-08-07
Schneyer Mark C.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock5849.017.84
2026-08-05
2026-08-07
Schneyer Mark C.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock5849.029.0
2026-08-05
2026-08-07
Schneyer Mark C.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
5849.00.0
2026-07-30
2026-07-31
Thompson Elizabeth H.Z.S · Sale
Disposed
Common Stock50.026.17
2026-07-30
2026-07-31
Thompson Elizabeth H.Z.S · Sale
Disposed
Common Stock16508.026.13
2026-07-29
2026-07-31
Thompson Elizabeth H.Z.M · Exercise / conversion
Acquired
Common Stock32272.0n/a
2026-07-29
2026-07-31
Thompson Elizabeth H.Z.M · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
32272.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001070494ACADIA PHARMACEUTICALS INC

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Acadia Pharmaceuticals · alias · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$957.80M$1.03B
2023-12-31$726.44M$803.25M
2022-12-31$517.24M$595.41M
2021-12-31$484.14M$601.91M
2020-12-31$441.75M$575.11M
2019-12-31$339.08M$446.85M
2018-12-31$223.81M$300.30M
2017-12-31$124.90M$171.68M

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗